Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery
Key Takeaways
- Concierge medicine and direct primary care both shrink physician panels and extend visit times. Concierge keeps insurance billing, while DPC uses a flat monthly fee with no insurance involvement.
- Concierge medicine supports lab-driven personalization, specialist coordination, and advanced therapies like peptides because labs and imaging can still be billed to insurance.
- Direct primary care is more affordable for routine care but does not cover specialists, imaging, or complex chronic-condition management, so patients still need separate insurance.
- Patients managing multiple chronic conditions, inflammation, or peptide protocols usually benefit most from concierge medicine’s 24/7 access, ongoing monitoring, and insurance integration.1
- For personalized peptide therapy and concierge-level wellness care, start with a consultation at Mirror Plastic Surgery with Ellie Pranckevicius, FNP-BC.
Concierge vs. DPC at a Glance
The following table shows how traditional primary care, direct primary care, and concierge medicine differ across core features such as panel size, visit length, insurance billing, and after-hours access so you can quickly see which model fits your needs.
| Feature | Traditional Primary Care | Direct Primary Care | Concierge Medicine |
|---|---|---|---|
| Avg. panel size | 2,000–3,000 patients | 300–600 patients | Under 600 patients |
| Typical visit length | 10–18 minutes | 45–60 minutes | 45–90+ minutes |
| Insurance billing | Yes, for all services | No insurance billing | Hybrid: membership fee + insurance for covered services |
| Lab/imaging coverage | Billed to insurance | Not covered; requires separate insurance | Billed to insurance alongside membership |
| After-hours access | Nurse line or triage | Varies by clinic | Direct cell/text/email, commonly 24/7 |
| Lab-driven customization | Reactive, episodic | Limited by scope | Proactive, longitudinal, protocol-level |
Key Tradeoffs of Concierge Medicine
Cost is the most frequently cited downside of concierge medicine. Contemporary programs charge a membership fee on top of existing insurance premiums, which places concierge care beyond many household budgets.
Geographic access is another limitation. Concierge practices cluster in metropolitan and affluent suburban areas, so rural patients often have few options. This pattern can create financial and geographic barriers that translate into different levels of care based on economic status.
Regulatory complexity also matters. If a concierge practice accepts Medicare or commercial insurance, the membership fee cannot be charged for any service already covered by those payers, and some commercial payer agreements may specifically prohibit any patient membership fee. Patients should confirm how their specific plan interacts with a chosen concierge practice before enrolling.
Panel size within concierge medicine varies widely, and that variation directly affects access. Panels above 600 patients function closer to a traditional practice with a membership fee attached, which dilutes the core benefit of concierge care. Panels below 300 usually deliver the extended visit times and near-constant availability that define true concierge medicine. Because this distinction is rarely advertised, prospective members should ask for the practice’s current panel count before committing, since panel size is a strong predictor of real-world access.
Key Tradeoffs of Direct Primary Care
Scope is DPC’s core limitation. DPC does not cover specialist visits, emergency department care, hospitalizations, or major procedures. Patients still need a separate insurance policy or health-sharing arrangement for anything beyond routine primary care, so the total cost of care is more complex than the monthly subscription suggests.
Patients with complex or evolving conditions may feel constrained by DPC’s defined service scope. Lower-cost DPC practices often have less capacity than concierge medicine for complex longitudinal management and for coordination outside primary care, such as specialist referrals.
After-hours access in DPC is not uniform. Many practices offer some evening or weekend support, but overnight or 24/7 availability varies by clinic and provider in both DPC and concierge settings. Concierge practices are more likely to guarantee 24/7 direct access.
DPC also carries regulatory risk. DPC models can draw scrutiny if the service scope resembles a healthcare service plan under state law. Patients in states with stricter insurance regulations should verify their DPC agreement’s legal standing.
Given these structural differences in scope and coverage, the choice between concierge and DPC becomes especially important for patients managing chronic conditions, where diagnostic depth and specialist coordination can directly affect outcomes.
Concierge vs DPC for Chronic Conditions
Both models outperform traditional primary care for chronic condition management because of smaller panels and longer visits.1 Patients with diabetes, hypertension, or asthma often report better communication and fewer hurdles for advice between visits under DPC.1 For straightforward chronic conditions that mainly need medication titration and lifestyle coaching, DPC offers a clear improvement over a 2,500-patient traditional panel.
Concierge medicine holds a structural advantage when conditions require advanced diagnostics, specialist coordination, or protocol-level personalization. A 2024 literature review linked concierge models with higher patient satisfaction, greater engagement, and fewer hospitalizations.1 Patients managing multiple chronic conditions often see earlier issue detection, improved specialist coordination, fewer ER and urgent-care visits, and more consistent medication management under concierge care.1
Patients pursuing advanced wellness therapies, such as peptide protocols for inflammation, metabolic health, or cellular aging, usually gain a financial advantage from concierge insurance integration.1 Labs and imaging ordered to monitor those protocols can be billed to the patient’s plan rather than paid entirely out of pocket, which matters when protocols require repeated hormone panels, metabolic markers, or organ-function screening.
How Insurance Interacts with Each Model
In a DPC practice, the monthly fee covers essentially everything the primary care office provides, and the practice does not bill insurance at all. Patients pay the subscription directly and maintain a separate insurance policy for everything outside the DPC scope, including specialists, imaging, hospitalizations, and emergency care.
Concierge medicine works differently. Concierge practices may accept Medicare or commercial insurance while charging a membership fee for premium access, such as extended time and direct communication. As noted earlier, regulatory rules govern what can be billed separately versus covered by the membership. In practice, insurance continues to process claims for labs, imaging, specialist visits, and hospitalizations.
Some concierge memberships may be HSA or FSA eligible while patients keep their existing Medicare or commercial insurance for non-membership services. Patients should confirm HSA or FSA eligibility with their plan administrator, since IRS guidance on membership fees continues to evolve.
With the structural and financial differences between these models clear, the next step is choosing which approach fits your health profile and goals.
Patient-Type Decision Matrix
Use this matrix to match your situation to the care model that fits best. Each row pairs a common patient profile with the recommended model and the main clinical reason behind that recommendation.
| Patient Profile | Recommended Model | Key Reason |
|---|---|---|
| Chronic inflammation or autoimmune management | Concierge | Requires repeated lab panels, specialist coordination, and protocol adjustment over time |
| Weight optimization with metabolic monitoring | Concierge | Thyroid, liver, kidney, hormone, and lipid panels billable to insurance alongside membership |
| Post-surgical recovery support | Concierge | 24/7 direct access and proactive wound or inflammation monitoring reduce complication risk |
| Anti-aging and collagen support | Concierge | Longitudinal biomarker tracking and peptide protocol oversight require depth of access |
| Anxiety or energy concerns, otherwise healthy | DPC or Concierge | DPC adequate for straightforward cases, concierge preferred when nootropic or peptide protocols are involved |
| Routine preventive care, no complex conditions | DPC | Affordable access model sufficient, specialist and lab needs manageable through separate insurance |
2026 Landscape: Concierge Growth and Peptide-Focused Care
The concierge medicine market is estimated at USD 24.03 billion in 2026 and projected to reach USD 47.14 billion by 2033 at a CAGR of 10.1%. Technavio projects the U.S. segment will grow by USD 3.36 billion from 2025 to 2030 at a CAGR of 7.9%. Demand for preventive care, chronic disease management, and precision wellness drives this growth, and these categories increasingly include peptide and longevity therapies.
The U.S. concierge market is expanding into longevity, precision medicine, and preventive services such as genomic screening. Peptide protocols for inflammation, metabolic health, cellular energy, and tissue repair align with this shift. Since many peptides are not FDA-regulated, the quality of medical supervision and sourcing becomes the main safety variable. High-quality programs rely on pharmacies that provide documented batch testing and pair that sourcing with baseline and follow-up lab panels, which clearly separates supervised concierge-level peptide therapy from unmonitored online purchasing.
Hybrid concierge models now combine in-person visits with telehealth, remote monitoring tools, and real-time vital tracking to support continuous connectivity. For peptide patients, this structure allows protocol adjustments, side-effect monitoring, and lab review between in-person visits without a separate office appointment.
This hybrid, protocol-driven approach to peptide therapy requires a provider with both clinical depth and aesthetic insight, someone who understands physiology and the outcomes patients want. That combination defines Ellie Pranckevicius’s work at Mirror Plastic Surgery.
Practitioner Expertise at Mirror Plastic Surgery
Ellie Pranckevicius, FNP-BC, leads peptide therapies and non-surgical aesthetics at Mirror Plastic Surgery in St. Petersburg, Florida. She holds a Bachelor’s in Health Science from Boston University, completed an aesthetics licensure program, and earned both her Bachelor’s and Master’s in Nursing from the University of South Florida. Her clinical foundation includes four years in the Neuroscience ICU at Tampa General Hospital, where she developed deep expertise in physiology, metabolic health, and complex patient management.
Ellie’s dual background in esthetic care and advanced nursing gives her a precise understanding of the aesthetic outcomes patients seek and the clinical science required to achieve them safely through personalized, lab-informed peptide protocols.

Book an appointment with Ellie to begin a concierge-level consultation that includes a full medical history review, lab panel analysis, and a custom peptide protocol tailored to your health profile.
How Concierge Peptide Care Works at Mirror
A concierge-level peptide consultation at Mirror Plastic Surgery starts with a 30–60 minute intake that covers medical history, current medications, lifestyle factors, and wellness goals. When appropriate, especially for weight optimization, inflammatory conditions, or hormone-related concerns, Ellie reviews existing lab panels or orders new testing that includes thyroid, liver, kidney, diabetes markers, and hormone levels. These results guide a custom peptide stack and dosing protocol specific to each patient’s physiology.
Ongoing access defines the experience. Patients communicate directly with Ellie by text for questions, side-effect monitoring, and refill requests, and they can schedule telemedicine appointments for more detailed follow-up. Protocol adjustments follow lab trends and patient-reported outcomes rather than a fixed calendar. The full process, from initial consultation through prescription and shipping, is available in person at the St. Petersburg clinic or remotely across the United States.
Risks, Limitations, and Common Challenges
Peptide therapies involve real considerations that any supervised program should address clearly. As discussed earlier, many peptides fall outside FDA regulation, so product quality from unverified online sources becomes the primary risk. Without third-party batch testing, active ingredient concentration and purity remain unknown. Mirror Plastic Surgery works only with pharmacies that provide documented batch testing, which directly addresses this concern.
Maintenance functions as a structural requirement. Stopping a peptide protocol usually leads to a return to baseline for the condition being managed, similar to stopping a long-term fitness or nutrition plan. Patients should approach peptide therapy with realistic expectations about long-term engagement and periodic lab review.
Individual response varies widely. Genetics, diet, lifestyle, baseline lab values, and the specific peptide or stack all influence outcomes.1 A protocol that produces measurable improvement in one patient may need adjustment for another.1 This variability makes a thorough initial assessment and ongoing monitoring essential parts of responsible concierge-level peptide care.
The individual end-user segment now represents a significant share of the concierge medicine market, which reflects growing awareness of personalized, lab-driven care. That awareness should always come with equal scrutiny of the supervision and sourcing standards behind any peptide program a patient considers.
Frequently Asked Questions
Is concierge medicine the same as direct primary care?
No. Both models reduce panel sizes and extend visit lengths compared with traditional primary care, but they differ structurally. Concierge medicine keeps an insurance relationship, billing covered services like labs, imaging, and specialist visits to the patient’s plan while charging a separate membership fee for premium access and time. Direct primary care removes insurance billing entirely and covers a defined scope of primary care services through a flat monthly subscription. Patients who need advanced diagnostics, specialist coordination, or protocol-level oversight, including peptide therapies, usually find concierge medicine better suited to those needs.
Are peptide therapies safe under medical supervision?
Sourcing and supervision represent the primary safety variables with peptides. Products from unverified online sources carry unknown purity and concentration. Under supervised concierge care, peptides come from pharmacies with documented batch testing, baseline labs screen for contraindications, dosing is individualized, and ongoing monitoring catches adverse trends early. Patients with pre-existing conditions or those on other medications benefit most from this supervised approach, since certain peptides require careful screening before use.
What happens if I stop a peptide protocol?
Benefits from peptide therapy usually persist only with continued use.1 If a protocol manages chronic inflammation, stopping it typically allows inflammation to return to its prior state. This pattern mirrors most ongoing health interventions, such as fitness regimens or dietary changes. Ellie designs maintenance protocols to sustain results at the lowest effective dose, and regular lab panels help determine when protocols can be adjusted or tapered.
Who is a good candidate for concierge-level peptide therapy?
Ideal candidates are adults managing chronic inflammation, autoimmune conditions, weight, post-surgical recovery, declining collagen production, reduced energy, or anxiety who have not reached their goals with conventional treatments alone. Candidates should be ready to share a full medical history, complete baseline lab work, and commit to a maintenance protocol. Patients who value direct, honest communication and want to understand the physiology behind each recommendation, rather than simply receiving a prescription, tend to fit well with the Mirror Plastic Surgery model.
Can I use my insurance for peptide therapies?
Peptide medications themselves are generally not covered by insurance because most are not FDA-regulated. Under a concierge model, however, the lab panels used to evaluate candidacy and monitor progress, including thyroid, liver, kidney, hormone, and metabolic markers, may be billable to your existing insurance plan. This structure gives concierge medicine a clear advantage over direct primary care for advanced wellness protocols, since the diagnostic work that supports therapy can often run through insurance and reduce out-of-pocket monitoring costs.
Making an Informed Choice
Concierge medicine and direct primary care both improve on traditional high-volume primary care, and the right choice depends on your health complexity, insurance situation, and desired level of oversight. For patients pursuing lab-driven, protocol-level therapies, including peptides for inflammation, metabolic health, anti-aging, or recovery, concierge medicine’s combination of extended access, insurance integration, and longitudinal monitoring provides a strong structural foundation. Mirror Plastic Surgery’s concierge approach, led by Ellie Pranckevicius, applies that standard to every in-person and remote patient.
Ready to explore whether concierge-level peptide therapy fits your goals? Start with a consultation to review your health profile, examine your labs, and design a protocol tailored to your physiology.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.


